甲状腺功能亢进症病证结合诊疗指南

2021-01-30 中国医师协会中西医结合医师分会 世界中医药.2021.16(1):93-96.

甲状腺功能亢进症简称“甲亢”,是甲状腺激素分泌过多导致机体兴奋性增高和代谢亢进为主要表现的一组临床综合征,Graves病是其最常见类型。本病属中医“瘿病&rdquo

中文标题:

甲状腺功能亢进症病证结合诊疗指南

发布日期:

2021-01-30

简要介绍:

甲状腺功能亢进症简称“甲亢”,是甲状腺激素分泌过多导致机体兴奋性增高和代谢亢进为主要表现的一组临床综合征,Graves病是其最常见类型。本病属中医“瘿病”“瘿气”范畴,中医治疗优势独特。本指南由中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会组织编写,供临床医师在采用病证结合方法治疗Graves病时参考使用,其他原因引起的甲亢,也可参照本指南诊疗。

相关资料下载:
[AttachmentFileName(sort=1, fileName=甲状腺功能亢进症病证结合诊疗指南_2021_01_20_.pdf)] GetToolGuiderByIdResponse(projectId=1, id=18ec41c00206e553, title=甲状腺功能亢进症病证结合诊疗指南, enTitle=, guiderFrom=世界中医药.2021.16(1):93-96., authorId=0, author=, summary=甲状腺功能亢进症简称“甲亢”,是甲状腺激素分泌过多导致机体兴奋性增高和代谢亢进为主要表现的一组临床综合征,Graves病是其最常见类型。本病属中医“瘿病&rdquo, cover=https://img.medsci.cn/202138/1615138568749_2020535.jpg, journalId=0, articlesId=null, associationId=990, associationName=中国医师协会中西医结合医师分会, associationIntro=中国医师协会中西医结合医师分会(Doctor Society of integrative Medicine,Chinese Medical Doctor Association,DSIM/CMDA,以下简称分会)是由中华人民共和国卫生部主管,中华人民共和国民政部批准注册,隶属中国医师协会的二级学会组织,于2007年11月9日至10日在北京正式成立。享誉国内外的著名中西医结合专家陈可冀院士担任会长,以中国中医科学院西苑医院为依托单位,由来自全国26省市地区及香港特别行政区的代表共128人组成了第一届委员会,充分体现了广泛的学术和区域代表性。由具备长期从事中西医结合工作经历的执业医师、管理人员及团体组成的全国性、行业性、非盈利性的群众组织,分会本着中国医师协会&ldquo;服务、协调、自律、维权、监督、管理&rdquo;宗旨,致力于加强中西医结合医师队伍的建设和管理,弘扬以人为本、救死扶伤的人道主义,维护我国中西医结合医师的正当义务权益,发挥中西医结合的特色与互补优势,促进中西医学术交流,提高临床综合服务能力,弘杨传统中医药学术的继承和发展,为我国人民健康和社会主义建设服务。, copyright=0, guiderPublishedTime=Sat Jan 30 00:00:00 CST 2021, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>甲状腺功能亢进症简称&ldquo;甲亢&rdquo;,是甲状腺激素分泌过多导致机体兴奋性增高和代谢亢进为主要表现的一组临床综合征,Graves病是其最常见类型。本病属中医&ldquo;瘿病&rdquo;&ldquo;瘿气&rdquo;范畴,中医治疗优势独特。本指南由中国医师协会中西医结合医师分会内分泌与代谢病学专业委员会组织编写,供临床医师在采用病证结合方法治疗Graves病时参考使用,其他原因引起的甲亢,也可参照本指南诊疗。</p> </div> </div> </div>, tagList=[TagDto(tagId=12478, tagName=甲状腺功能亢进症)], categoryList=[CategoryDto(categoryId=6, categoryName=内分泌科, tenant=100), CategoryDto(categoryId=73, categoryName=头颈外科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=12478, guiderKeyword=甲状腺功能亢进症, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=10, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=12802, appHits=866, showAppHits=0, pcHits=1214, showPcHits=11934, likes=4, shares=68, comments=49, approvalStatus=1, publishedTime=Mon Mar 08 01:49:10 CST 2021, publishedTimeString=2021-01-30, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=3, createdBy=null, createdName=qiushida2, createdTime=Mon Mar 08 01:36:14 CST 2021, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 22:02:33 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=甲状腺功能亢进症病证结合诊疗指南_2021_01_20_.pdf)])
甲状腺功能亢进症病证结合诊疗指南_2021_01_20_.pdf
下载请点击:
评论区 (41)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2092469, encodeId=1516209246949, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbf5448904, createdName=ms3000001417319363, createdTime=Sat Oct 08 12:07:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222390, encodeId=13f41222390f3, content=厉害👍 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4288179451, createdName=ms1000001047659996, createdTime=Wed May 25 19:48:00 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197005, encodeId=140e119e005f9, content=对临床诊疗很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Thu Feb 24 21:14:08 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194797, encodeId=36271194e9706, content=n, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea916425920, createdName=ms6000001125232362, createdTime=Fri Feb 18 13:01:58 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194288, encodeId=90ad119428802, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4d92110516, createdName=buku, createdTime=Thu Feb 17 08:05:56 CST 2022, time=2022-02-17, status=1, ipAttribution=)]
    2022-10-08 ms3000001417319363

    很有用

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2092469, encodeId=1516209246949, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbf5448904, createdName=ms3000001417319363, createdTime=Sat Oct 08 12:07:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222390, encodeId=13f41222390f3, content=厉害👍 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4288179451, createdName=ms1000001047659996, createdTime=Wed May 25 19:48:00 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197005, encodeId=140e119e005f9, content=对临床诊疗很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Thu Feb 24 21:14:08 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194797, encodeId=36271194e9706, content=n, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea916425920, createdName=ms6000001125232362, createdTime=Fri Feb 18 13:01:58 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194288, encodeId=90ad119428802, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4d92110516, createdName=buku, createdTime=Thu Feb 17 08:05:56 CST 2022, time=2022-02-17, status=1, ipAttribution=)]
    2022-05-25 ms1000001047659996

    厉害👍

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2092469, encodeId=1516209246949, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbf5448904, createdName=ms3000001417319363, createdTime=Sat Oct 08 12:07:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222390, encodeId=13f41222390f3, content=厉害👍 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4288179451, createdName=ms1000001047659996, createdTime=Wed May 25 19:48:00 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197005, encodeId=140e119e005f9, content=对临床诊疗很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Thu Feb 24 21:14:08 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194797, encodeId=36271194e9706, content=n, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea916425920, createdName=ms6000001125232362, createdTime=Fri Feb 18 13:01:58 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194288, encodeId=90ad119428802, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4d92110516, createdName=buku, createdTime=Thu Feb 17 08:05:56 CST 2022, time=2022-02-17, status=1, ipAttribution=)]
    2022-02-24 ms3000000190198551

    对临床诊疗很有用

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2092469, encodeId=1516209246949, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbf5448904, createdName=ms3000001417319363, createdTime=Sat Oct 08 12:07:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222390, encodeId=13f41222390f3, content=厉害👍 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4288179451, createdName=ms1000001047659996, createdTime=Wed May 25 19:48:00 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197005, encodeId=140e119e005f9, content=对临床诊疗很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Thu Feb 24 21:14:08 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194797, encodeId=36271194e9706, content=n, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea916425920, createdName=ms6000001125232362, createdTime=Fri Feb 18 13:01:58 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194288, encodeId=90ad119428802, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4d92110516, createdName=buku, createdTime=Thu Feb 17 08:05:56 CST 2022, time=2022-02-17, status=1, ipAttribution=)]
    2022-02-18 ms6000001125232362

    n

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2092469, encodeId=1516209246949, content=很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=1cbf5448904, createdName=ms3000001417319363, createdTime=Sat Oct 08 12:07:09 CST 2022, time=2022-10-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1222390, encodeId=13f41222390f3, content=厉害👍 , beContent=null, objectType=guider, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d4288179451, createdName=ms1000001047659996, createdTime=Wed May 25 19:48:00 CST 2022, time=2022-05-25, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1197005, encodeId=140e119e005f9, content=对临床诊疗很有用, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=198f5456588, createdName=ms3000000190198551, createdTime=Thu Feb 24 21:14:08 CST 2022, time=2022-02-24, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194797, encodeId=36271194e9706, content=n, beContent=null, objectType=guider, channel=null, level=null, likeNumber=49, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ea916425920, createdName=ms6000001125232362, createdTime=Fri Feb 18 13:01:58 CST 2022, time=2022-02-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1194288, encodeId=90ad119428802, content=不错, beContent=null, objectType=guider, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f4d92110516, createdName=buku, createdTime=Thu Feb 17 08:05:56 CST 2022, time=2022-02-17, status=1, ipAttribution=)]
    2022-02-17 buku

    不错

    0